Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear Cells 2 to 3 Weeks Following Acute Myocardial Infarction on Left Ventricular Function: The LateTIME Randomized Trial
Interview with Jay H. Traverse, MD, author of Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear Cells 2 to 3 Weeks Following Acute Myocardial Infarction on Left Ventricular Function: The LateTIME Randomized Trial (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - November 15, 2011 Category: Journals (General) Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts
JAMA: 2011-11-16, Vol. 306, No. 19, Author Interview
Interview with Jay H. Traverse, MD, author of Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear Cells 2 to 3 Weeks Following Acute Myocardial Infarction on Left Ventricular Function: The LateTIME Randomized Trial (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - November 15, 2011 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
The Lancet: February 25, 2011
Tim Nawrot discusses the public health implications of triggers for non-fatal myocardial infarction. (Source: Listen to The Lancet)
Source: Listen to The Lancet - February 25, 2011 Category: General Medicine Authors: The Lancet Source Type: podcasts
Calcium and Heart Attack Risk: Ending the Confusion
Could IOM-recommended calcium intakes pose concern for increased myocardial infarction risk? Dr. JoAnn Manson clarifies whether the results of a recent meta-analysis affect guidance on supplementation. (Source: Medscape Orthopaedics Podcast)
Source: Medscape Orthopaedics Podcast - January 11, 2011 Category: Orthopaedics Authors: Medscape Source Type: podcasts
The Lancet: February 26, 2010
Ischaemic preconditioning for patients with acute myocardial infarction. (Source: Listen to The Lancet)
Source: Listen to The Lancet - February 26, 2010 Category: Journals (General) Authors: The Lancet Source Type: podcasts
The Lancet: August 15, 2008
Interview with Dr van't Hof on tirofiban administered in the ambulance setting after myocardial infarction. (Source: Listen to The Lancet)
Source: Listen to The Lancet - August 15, 2008 Category: Journals (General) Authors: The Lancet Source Type: podcasts
The Lancet: July 18, 2008
Risk markers of coronary heart disease: apolipoproteins and cholesterol as indices of risk for myocardial infarction are assessed in a large case-control study, and discussed in a podcast. (Source: Listen to The Lancet)
Source: Listen to The Lancet - July 18, 2008 Category: General Medicine Authors: The Lancet Source Type: podcasts
The Lancet: June 06, 2008
A review highlights how moderate hypothermia - reducing core body temperature to around 35C - is underused in clinical practice after traumatic events such as heart attack, stroke, and traumatic brain injury. Author Kees Polderman discusses the potential of moderate hypothermia in this week's podcast. (Source: Listen to The Lancet)
Source: Listen to The Lancet - June 6, 2008 Category: General Medicine Authors: The Lancet Source Type: podcasts
The Lancet: April 04, 2008
Doubts over the long-term safety of the HIV nucleoside reverse transcriptase inhibitor abacavir and the less commonly used antiretroviral drug didanosine are raised in a research Article. Both drugs were found to be associated with an increased risk of myocardial infarction. Jens Lundgren (University of Copenhagen, Denmark) discusses the study in this week's podcast. (Source: Listen to The Lancet)
Source: Listen to The Lancet - April 4, 2008 Category: General Medicine Authors: The Lancet Source Type: podcasts
